Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia

Biological Trace Element Research

Volumn 148, Issue 2, 2012, Pages 216-223

  Aydemir, Mustafa ^a   Ozturk, Nihal ^a   Dogan, Serdar ^a   Aslan, Mutay ^a   Olgar, Yusuf ^a   Ozdemir, Semir ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Contractility; Intracellular calcium; Ion channels; Oxidative Stress; Sodium tungstate; Type 1 diabetes

Indexed keywords

CALCIUM ION; CARBONYL DERIVATIVE; GLUCOSE; INSULIN; POTASSIUM; SODIUM; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUNGSTATE SODIUM; UNCLASSIFIED DRUG; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE CELL; HEART WEIGHT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MOLECULAR DYNAMICS; NONHUMAN; RAT; TREATMENT RESPONSE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALCIUM; CALCIUM CHANNELS, L-TYPE; CARDIOTONIC AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHYSIOLOGICAL PHENOMENA; HEART; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; ORGAN SIZE; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUNGSTEN COMPOUNDS; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMALIA; RATTUS;

EID: 84864723473     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9350-8     Document Type: Article

References (44)

1. Jourdon P, Feuvray D (1993) Calcium and potassium currents in ventricular myocytes isolated from diabetic rats. J Physiol 470:411- 429 (Pubitemid 23322497)
2. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B (2004) Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426:83-90. doi:j. taap.2010.04.021/j.abb.2004.03.030 (Pubitemid 38595133)
3. Ozdemir S, Ugur M, Gürdal H, Turan B (2005) Treatment with AT(1) receptor blocker restores diabetes-induced alterations in intracellular Ca(2+) transients and contractile function of rat myocardium. Arch Biochem Biophys 435:166-174. doi:j. taap.2010.04.021/j.abb.2004.11.027 (Pubitemid 40170027)
4. Fein F, Kornstein L, Strobeck J, Capasso J, Sonnenblick E (1980) Altered myocardial mechanics in diabetic rats. Circ Res 47:922-933 (Pubitemid 11217058)
5. Shao CH, Rozanski GJ, Patel KP, Bidasee KR (2007) Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocininduced diabetic rats. J Mol Cell Cardiol 42:234-246. doi:j. taap.2010.04.021/j.yjmcc.2006.08.018 (Pubitemid 44958613)
6. Lacombe VA, Viatchenko-Karpinski S, Terentyev D, Sridhar A, Emani S, Bonagura JD, Feldman DS, Györke S, Carnes CA (2007) Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol 293:R1787-R1797. doi:10.1152/ajpregu.00059. 2007 (Pubitemid 350085654)
7. Bracken N, Howarth FC, Singh J (2006) Effects of streptozotocininduced diabetes on contraction and calcium transport in rat ventricular cardiomyocytes. Ann N Y Acad Sci 1084:208-222. doi:10.1196/annals.1372.018 (Pubitemid 47091952)
8. Shimoni Y, Firek L, Severson D, Giles W (1994) Short-term diabetes alters K+ currents in rat ventricular myocytes. Circ Res 74:620-628 (Pubitemid 24088522)
9. Rozanski GJ, Xu Z (2002) A metabolic mechanism for cardiac K+ channel remodelling. Clin Exp Pharmacol Physiol 29:132-137 (Pubitemid 34093991)
10. Li X, Xu Z, Li S, Rozanski GJ (2005) Redox regulation of Ito remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288:H1417-H1424. doi:10.1152/ajpheart.00559.2004 (Pubitemid 40270053)
11. Gallego M, Alday A, Urrutia J, Casis O (2009) Transient outward potassium channel regulation in healthy and diabetic hearts. Can J Physiol Pharmacol 87:77-83. doi:10.1139/Y08-106
12. Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213-3223. doi:10.1161/CIRCULATIONAHA.106.679597 (Pubitemid 47012236)
13. Cesario DA, Brar R, Shivkumar K (2006) Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol Metab Clin North Am 35:601-610. doi:j.taap.2010.04.021/j. ecl.2006.05.002, ix-x (Pubitemid 44321949)
14. Choi K, Zhong Y, Hoit B, Grupp I, Hahn H, Dilly K, Guatimosim S, Lederer W, Matlib M (2002) Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283:H1398-H1408
15. Duan J, Zhang HY, Adkins SD, Ren BH, Norby FL, Zhang X, Benoit JN, Epstein PN, Ren J (2003) Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. Am J Physiol Endocrinol Metab 284:E366- E376. doi:10.1152/ajpendo.00254.2002 (Pubitemid 36120110)
16. Stølen TO, Høydal MA, Kemi OJ, Catalucci D, Ceci M, Aasum E, Larsen T, Rolim N, Condorelli G, Smith GL, Wisløff U (2009) Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 105:527-536. doi:10.1161/CIRCRESAHA.109.199810
17. Belke DD, Swanson EA, Dillmann WH (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53:3201-3208 (Pubitemid 39564496)
18. Yaras N, Ugur M, Ozdemir S, Gurdal H, Purali N, Lacampagne A, Vassort G, Turan B (2005) Effects of diabetes on ryanodine receptor Ca release channel (RyR2) and Ca2+ homeostasis in rat heart. Diabetes 54:3082-3088 (Pubitemid 43334359)
19. Hattori Y, Matsuda N, Kimura J, Ishitani T, Tamada A, Gando S, Kemmotsu O, Kanno M (2000) Diminished function and expression of the cardiac Na+-Ca2+ exchanger in diabetic rats: implication in Ca2+ overload. J Physiol 527(Pt 1):85-94 (Pubitemid 30649586)
20. Norby F, Wold L, Duan J, Hintz K, Ren J (2002) IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283:E658-E666
21. Teshima Y, Takahashi N, Saikawa T, Hara M, Yasunaga S, Hidaka S, Sakata T (2000) Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+) channel mRNA in streptozotocin-induced diabetic rat heart. J Mol Cell Cardiol 32:655-664 (Pubitemid 30658934)
22. Ren J, Duan J, Thomas DP, Yang X, Sreejayan N, Sowers JR, Leri A, Kajstura J, Gao F, Anversa P (2008) IGF-I alleviates diabetesinduced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am J Physiol Regul Integr Comp Physiol 294:R793- R802. doi:10.1152/ajpregu.00713.2007 (Pubitemid 351346955)
23. Shao CH, Wehrens XH, Wyatt TA, Parbhu S, Rozanski GJ, Patel KP, Bidasee KR (2009) Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation. J Appl Physiol 106:1280-1292. doi:10.1152/japplphysiol. 91280.2008
24. Nagareddy PR, Vasudevan H, McNeill JH (2005) Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 83:405-411. doi:10.1139/y05-026 (Pubitemid 41003315)
25. Barberà A, Gomis RR, Prats N, Rodríguez-Gil JE, Domingo M, Gomis R, Guinovart JJ (2001) Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia 44:507-513. doi:10.1007/s001250100479 (Pubitemid 32324363)
26. Barberà A, Fernàndez-Alvarez J, Truc A, Gomis R, Guinovart JJ (1997) Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia 40:143-149 (Pubitemid 27060285)
27. Muñoz MC, Barberà A, Domínguez J, Fernàndez-Alvarez J, Gomis R, Guinovart JJ (2001) Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes 50:131-138 (Pubitemid 32047991)
28. Barberà A, Rodríguez-Gil JE, Guinovart JJ (1994) Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J Biol Chem 269:20047-20053
29. Ozdemir S, Bito V, Holemans P, Vinet L, Mercadier JJ, Varro A, Sipido KR (2008) Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block. Circ Res 102:1398-1405. doi:10.1161/CIRCRESAHA.108.173922
30. Bito V, de Waard MC, Biesmans L, Lenaerts I, Ozdemir S, van Deel E, Abdel-Mottaleb Y, Driesen R, Holemans P, Duncker DJ, Sipido KR (2010) Early exercise training after myocardial infarction prevents contractile but not electrical remodelling or hypertrophy. Cardiovasc Res 86:72-81. doi:10.1093/cvr/cvp381
31. Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA (1989) A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 6:607-615 (Pubitemid 19147811)
32. Curek GD, Cort A, Yucel G, Demir N, Ozturk S, Elpek GO, Savas B, Aslan M (2010) Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology 267:147-153. doi:j. taap.2010.04.021/j.tox. 2009.11.003
33. Wasowicz W, Nève J, Peretz A (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 39:2522-2526 (Pubitemid 24008241)
34. Ballester J, Muñoz MC, Domínguez J, Palomo MJ, Rivera M, Rigau T, Guinovart JJ, Rodríguez-Gil JE (2007) Tungstate administration improves the sexual and reproductive function in female rats with streptozotocin-induced diabetes. Hum Reprod 22:2128-2135. doi:10.1093/humrep/ dem168 (Pubitemid 47241857)
35. Fierabracci V, De Tata V, Pocai A, Novelli M, Barberà A, Masiello P (2002) Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine 19:177-184. doi:10.1385/ENDO:19:2:177 (Pubitemid 36160728)
36. McInturf SM, Bekkedal MY, Wilfong E, Arfsten D, Gunasekar PG, Chapman GD (2008) Neurobehavioral effects of sodium tungstate exposure on rats and their progeny. Neurotoxicol Teratol 30:455-461. doi:j.taap.2010.04.021/j.ntt.2008.07. 003
37. McInturf SM, Bekkedal MY, Wilfong E, Arfsten D, Chapman G, Gunasekar PG (2011) The potential reproductive, neurobehavioral and systemic effects of soluble sodium tungstate exposure in Sprague-Dawley rats. Toxicol Appl Pharmacol. doi:j. taap.2010.04.021/j.taap.2010.04.021
38. Shimoni Y (2001) Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes. J Physiol 537:83-92 (Pubitemid 33076956)
39. Bidasee KR, Nallani K, Besch HR, Dincer UD (2003) Streptozotocininduced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2). J Pharmacol Exp Ther 305:989-998. doi:10.1124/jpet.102.046201 (Pubitemid 36617976)
40. Dhalla N, Liu X, Panagia V, Takeda N (1998) Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40:239-247 (Pubitemid 28506032)
41. Akki A, Zhang M, Murdoch C, Brewer A, Shah AM(2009) NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47:15-22. doi:j.taap.2010.04.021/j.yjmcc.2009.04.004
42. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A (2003) Protein carbonylation in human diseases. Trends MolMed 9:169-176 (Pubitemid 36626706)
43. Nakhaee A, Bokaeian M, Akbarzadeh A, Hashemi M (2010) Sodium tungstate attenuate oxidative stress in brain tissue of streptozotocin-induced diabetic rats. Biol Trace Elem Res 136:221-231. doi:10.1007/s12011-009-8537-0
44. Desco MC, Asensi M, Márquez R, Martínez-Valls J, Vento M, Pallardó FV, Sastre J, Viña J (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51:1118-1124 (Pubitemid 34438358)